Market Cap (In KRW)
178.38 Billion
Revenue (In KRW)
206.86 Billion
Net Income (In KRW)
28.14 Billion
Avg. Volume
35.69 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 10680.0-13550.0
- PE
- -
- EPS
- -
- Beta Value
- 0.635
- ISIN
- KR7234080000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sungnam Cha
- Employee Count
- -
- Website
- https://www.jw-lifescience.co.kr
- Ipo Date
- 2016-10-27
- Details
- JW Lifescience Corporation engages in the development, production, and sale of infusion solutions in South Korea and internationally. It offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin, South Korea.
More Stocks
-
300976
-
004100
-
1198
-
DAC
-
PGCRL
-
LDX
-
600289
-
301135